Literature DB >> 1709093

Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.

F Rösl1, T Achtstätter, T Bauknecht, K J Hutter, G Futterman, H zur Hausen.   

Abstract

'Universal fuser' clones of a human papillomavirus type 16 positive cervical carcinoma cell line (SiHa) were established to study the effect of a non-tumorigenic fusion partner on the regulation of a stably integrated chloramphenicol acetyltransferase (CAT) gene controlled by the HPV18 upstream regulatory region under non-selective conditions. The CAT expressing cells were fused with both non-tumorigenic, spontaneously immortalized human keratinocytes (HaCaT) and non-modified SiHa cells. The resulting hybrids were characterized by restriction enzyme fragment length polymorphism analysis and flow cytometry. While the non-selectable, HPV18-driven indicator gene is constitutively expressed in SiHa cells, the CAT activity is extinguished in SiHa x HaCaT cells, but still present in SiHa x SiHa hybrids. Examination of the cytokeratin expression pattern reveals that the keratinocyte phenotype seems not only to be dominant in terms of the extinction of the HPV18 regulatory region but also by the conservation of most of the differentiation markers of the non-tumorigenic fusion partner. Cycloheximide treatment and intracellular competition experiments using the transient COS7 fusion-amplification technique are accompanied by the reactivation of the marker gene in previously CAT- SiHa x HaCaT hybrids. These data strongly suggest that trans-acting negative regulatory factors derived from the non-malignant human keratinocytes are responsible for the extinction phenomenon.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709093      PMCID: PMC452792          DOI: 10.1002/j.1460-2075.1991.tb07653.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  80 in total

1.  Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

Authors:  R Moll; T Achtstätter; E Becht; J Balcarova-Ständer; M Ittensohn; W W Franke
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

2.  Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen.

Authors:  W W Franke; R Moll
Journal:  Differentiation       Date:  1987       Impact factor: 3.880

3.  Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

Authors:  S T Cole; O Danos
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

4.  Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa.

Authors:  M K el Awady; J B Kaplan; S J O'Brien; R D Burk
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

5.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.

Authors:  C C Baker; W C Phelps; V Lindgren; M J Braun; M A Gonda; P M Howley
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Suppression of tumor growth by senescence in virally transformed human fibroblasts.

Authors:  W O'Brien; G Stenman; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

7.  Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA.

Authors:  H L Smits; E Raadsheer; I Rood; S Mehendale; R M Slater; J van der Noordaa; J ter Schegget
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Genes activated in the presence of an immunoglobulin enhancer or promoter are negatively regulated by a T-lymphoma cell line.

Authors:  D M Zaller; H Yu; L A Eckhardt
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

9.  Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine.

Authors:  F Rösl; M Dürst; H zur Hausen
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

10.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.

Authors:  P Boukamp; R T Petrussevska; D Breitkreutz; J Hornung; A Markham; N E Fusenig
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  11 in total

1.  Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression.

Authors:  J H Lichy; M Majidi; J Elbaum; M M Tsai
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

Review 2.  Roots and perspectives of contemporary papillomavirus research.

Authors:  H zur Hausen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.

Authors:  Anastasia Bachmann; Brigitte Hanke; Rainer Zawatzky; Ubaldo Soto; Jan van Riggelen; Harald zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription.

Authors:  F Rösl; B C Das; M Lengert; K Geletneky; H zur Hausen
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity.

Authors:  M J O'Connor; S H Tan; C H Tan; H U Bernard
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids.

Authors:  F Rösl; M Lengert; J Albrecht; K Kleine; R Zawatzky; B Schraven; H zur Hausen
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

Review 7.  The human papillomavirus E7 oncoprotein.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virology       Date:  2008-11-12       Impact factor: 3.616

Review 8.  The molecular genetics of cervical carcinoma.

Authors:  P A Lazo
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

9.  Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1.

Authors:  T Bauknecht; P Angel; H D Royer; H zur Hausen
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer.

Authors:  Edgar Grinstein; Peter Wernet; Peter J F Snijders; Frank Rösl; Inge Weinert; Wentao Jia; Regine Kraft; Christiane Schewe; Michael Schwabe; Steffen Hauptmann; Manfred Dietel; Chris J L M Meijer; Hans-Dieter Royer
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.